Tradestie Institutional Equity Comparison Engine

QURE vs TLX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

TLX Overall Edge

TLX Captures Institutional Edge (2โ€“2 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Telix Pharmaceuticals Limited American Depositary Shares (TLX) driven by superior Growth & Margin, Momentum & Technical while QURE counters with relative strength in Valuation, Options & Structure. Fundamentally, QURE trades at 27.9x Forward P/E with -994.0% operating margin (+40.4% YoY revenue) versus TLX at N/M Forward P/E and 6.2% operating margin (+22.3% YoY). In options structure, QURE sits in BREAKDOWN (<1st %ile IV; Dealer Gamma Walls on Pro) against TLX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner QURE
QURE 27.9x vs TLX N/M Fwd P/E
Growth & Margin Winner TLX
Op Margin -994.0% vs 6.2% ยท YoY +40.4% vs +22.3%
Momentum & Technical Winner TLX
1Y -27.2% vs -5.8% ยท 52W Pos 31% vs 39%
Options & Structure Winner QURE
BREAKDOWN (<1st %ile IV) vs UNCLASSIFIED (N/A IV)
QURE NASDAQ
uniQure N.V.
Pharmaceutical Preparations
$22.10
-7.18% 1D
Market Cap $1.7B
1M Return +1.47%
1Y Return -27.16%
Forward P/E 27.9x
Unified AI Score
48.9 / 100 HOLD
Tech 42.0 Fund 55.0 Flow 69.0 Mom 60.0
TLX NASDAQ
Telix Pharmaceuticals Limited American Depositary Shares
Pharmaceutical Preparations
$8.96
-2.98% 1D
Market Cap $3.2B
1M Return -16.23%
1Y Return -5.84%
Forward P/E N/M
Unified AI Score
46.4 / 100 HOLD
Tech 64.0 Fund 62.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: QURE -27.16% TLX -5.84% Spread: +21.32 pp (TLX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
QURE TTM Op. Margin: -994.0% TLX TTM Op. Margin: 6.2%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on QURE vs TLX. Trailing 12-month operating profitability (QURE -994.0% vs TLX 6.2%) and valuation multiples (QURE 27.9x vs TLX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: QURE (4) vs TLX (6)
Institutional Metric QURE TLX Criterion Row Winner
Market Capitalization Scale $1.7B $3.2B Larger Scale TLX
Trailing P/E Ratio Valuation 27.9x 93.6x Lower Multiple QURE
Forward P/E Ratio Valuation 27.9x N/M Lower Multiple QURE
Revenue Growth (YoY) Growth +40.4% +22.3% Higher Growth QURE
Operating Margin (TTM) Profitability -994.0% 6.2% Higher Margin TLX
Net Profit Margin Profitability 0.0% 3.8% Higher Margin TLX
Return on Equity (ROE) Capital Efficiency -89.0% 7.4% Higher ROE TLX
52-Week Range Position Momentum 31% ($9โ€“$52) 39% ($6โ€“$13) Stronger Trend TLX
Beta / 30D Volatility Risk Regime 0.81ฮฒ ยท 81% Vol 0.84ฮฒ ยท 62% Vol Lower Realized Risk TLX
Unified Institutional Score Composite Signal 48.9 / 100 (HOLD) 46.4 / 100 (HOLD) Higher Composite QURE

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full QURE vs TLX Buy Guide
QURE BREAKDOWN
102d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live QURE Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
TLX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live TLX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither QURE nor TLX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.